Phibro Animal Health (PAHC) Net Income towards Common Stockholders Growth (5y) (2017 - 2026)
Powered by 
Analysis
Phibro Animal Health (PAHC) Net Income towards Common Stockholders Growth (5y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.51 Bn | 40.32 Bn | 779.09 Mn |
| 2 | Zoetis | 30.62 Bn | 28.94 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.76% |
| Mar 31, 2026 | 14.59% |
| Dec 31, 2025 | 16.49% |
| Sep 30, 2025 | 16.61% |
| Jun 30, 2025 | 7.26% |
| Mar 31, 2025 | 9.11% |
| Dec 31, 2024 | -23.17% |
| Sep 30, 2024 | 22.63% |
| Jun 30, 2024 | 5.63% |
| Mar 31, 2024 | -10.76% |
| Dec 31, 2023 | -38.72% |
| Sep 30, 2023 | -20.03% |
| Jun 30, 2023 | -17.21% |
| Mar 31, 2023 | -12.73% |
| Dec 31, 2022 | 0.50% |
| Sep 30, 2022 | -24.67% |
| Jun 30, 2022 | -15.35% |
| Mar 31, 2022 | -5.64% |
| Dec 31, 2021 | 5.42% |
| Sep 30, 2021 | -11.71% |